PCI Biotech Holding ASA
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-2.38-1.30-6.94-24.21-21.57-31.99-14.32-5.86-1.42-3.85N/A-21.57
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A26.21N/AN/A
Price/Book Value ratio
9.390.9417.0724.792.2011.205.494.561.332.00N/A11.20
Price/Cash Flow ratio
-2.70-1.27-6.26-33.88-24.14-34.20-13.44-7.60-1.29-5.23N/A-24.14
Price/Free Cash Flow ratio
-2.70-1.27-6.26-33.88-24.14-32.12-12.79-7.56-1.29-5.23N/A-24.14
Price/Earnings Growth ratio
-0.040.031.331.940.74-0.340.76-0.270.030.06N/AN/A
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A100%N/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A-743.84%N/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A-679.43%N/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A-679.43%N/AN/A
Effective Tax Rate
-1.81%-2.21%-2.63%-1.37%-28.33%-0.57%-0.54%-0.10%2.45%N/AN/A-28.33%
Return on Assets
-175.84%-56.60%-143.69%-73.31%-9.74%-31.64%-34.73%-65.06%-84.65%-46.11%N/A-9.74%
Return On Equity
-393.24%-72.08%-245.94%-102.38%-10.23%-35.02%-38.38%-77.75%-93.62%-52.03%N/A-10.23%
Return on Capital Employed
-400.21%-73.68%-252.38%-99.04%-13.09%-34.49%-43.38%-74.76%-97.77%-56.91%N/A-13.09%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Quick Ratio
1.804.593.244.4921.4210.8410.096.0910.918.79N/A10.84
Cash ratio
1.344.011.443.4420.5110.559.435.509.738.27N/A10.55
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/A17.95-179.37-436.17K-511.87K3.34K132.08134.73N/AN/AN/A-511.87K
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A80.3647.7791.06K137.89K3.28K858.11537.94285.42N/AN/A3.28K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/A-0.01N/A-0.23N/AN/AN/AN/A
Debt Equity Ratio
N/AN/AN/AN/AN/A-0.01N/A-0.27N/AN/AN/AN/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/A-0.01N/A-0.38N/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/A24.13N/A2.14N/AN/AN/A24.13
Company Equity Multiplier
2.231.271.711.391.051.101.101.191.101.12N/A1.10
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-5.00N/AN/A
Free Cash Flow / Operating Cash Flow Ratio
111111.061.051.0011N/A1.06
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/A24.13N/A2.14N/AN/AN/A24.13
Short Term Coverage Ratio
N/AN/AN/AN/AN/A24.13N/A2.14N/AN/AN/A24.13
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A